783 related articles for article (PubMed ID: 14700170)
41. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
42. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
43. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
44. Epidemic measles in a highly vaccinated population.
Shasby DM; Shope TC; Downs H; Herrmann KL; Polkowski J
N Engl J Med; 1977 Mar; 296(11):585-9. PubMed ID: 65732
[TBL] [Abstract][Full Text] [Related]
45. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
[TBL] [Abstract][Full Text] [Related]
46. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
[TBL] [Abstract][Full Text] [Related]
47. Immune response to measles vaccine in Peruvian children.
Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
[TBL] [Abstract][Full Text] [Related]
48. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
Unalan H; Ustaçelebi S
Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
[TBL] [Abstract][Full Text] [Related]
49. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
Oyefolu AO; Omilabu SA
West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
[TBL] [Abstract][Full Text] [Related]
50. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
[TBL] [Abstract][Full Text] [Related]
51. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
52. Low antibody response in infants with measles and children with subclinical measles virus infection.
Cherian T; Joseph A; John TJ
J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
[TBL] [Abstract][Full Text] [Related]
53. Immune responses to measles immunization and the impacts on HIV-infected children.
Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
[TBL] [Abstract][Full Text] [Related]
54. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
[TBL] [Abstract][Full Text] [Related]
55. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
Aaby P; Ibrahim SA; Libman MD; Jensen H
Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
[TBL] [Abstract][Full Text] [Related]
56. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
[TBL] [Abstract][Full Text] [Related]
58. Measles control in a rural area in Zimbabwe.
Tumwine JK
East Afr Med J; 1991 Sep; 68(9):694-701. PubMed ID: 1797531
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
de Serres G; Boulianne N; Ratnam S; Corriveau A
Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
[TBL] [Abstract][Full Text] [Related]
60. Optimal age for measles vaccination.
Vidyashankar C
J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
